Literature DB >> 23027743

Crystallization and preliminary X-ray diffraction analysis of tau protein microtubule-binding motifs in complex with Tau5 and DC25 antibody Fab fragments.

Ondrej Cehlar1, Rostislav Skrabana, Andrej Kovac, Branislav Kovacech, Michal Novak.   

Abstract

The Alzheimer's disease-associated protein tau is an intrinsically disordered protein with no preferred structure in solution. Under physiological conditions, tau binds to microtubules and regulates their dynamics, whereas during the development of neurodegeneration tau dissociates from microtubules, misfolds and creates highly insoluble deposits. To elucidate the determinants of tau-protein misfolding, tau peptides from microtubule-binding motifs were crystallized in complexes with Fab fragments of specific monoclonal antibodies. The crystals diffracted to 1.69 Å resolution and gave complete data sets using a synchrotron X-ray source. Molecular replacement was used to solve the phase problem.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23027743      PMCID: PMC3497975          DOI: 10.1107/S1744309112030382

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  22 in total

1.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins.

Authors:  Rune Linding; Joost Schymkowitz; Frederic Rousseau; Francesca Diella; Luis Serrano
Journal:  J Mol Biol       Date:  2004-09-03       Impact factor: 5.469

Review 2.  The interplay between structure and function in intrinsically unstructured proteins.

Authors:  Peter Tompa
Journal:  FEBS Lett       Date:  2005-04-08       Impact factor: 4.124

3.  Structure solution of misfolded conformations adopted by intrinsically disordered Alzheimer's tau protein.

Authors:  Jozef Sevcik; Rostislav Skrabana; Eva Kontsekova; Michal Novak
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

4.  The "jaws" of the tau-microtubule interaction.

Authors:  Marco D Mukrasch; Martin von Bergen; Jacek Biernat; Daniela Fischer; Christian Griesinger; Eckhard Mandelkow; Markus Zweckstetter
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

Review 5.  Intrinsically disordered tau protein in Alzheimer's tangles: a coincidence or a rule?

Authors:  R Skrabana; M Skrabanova; N Csokova; J Sevcik; M Novak
Journal:  Bratisl Lek Listy       Date:  2006       Impact factor: 1.278

6.  Preparation, crystallization and preliminary X-ray analysis of the Fab fragment of monoclonal antibody MN423, revealing the structural aspects of Alzheimer's paired helical filaments.

Authors:  Natália Csóková; Rostislav Skrabana; L'ubica Urbániková; Branislav Kovácech; Alexander Popov; Jozef Sevcík; Michal Novák
Journal:  Protein Pept Lett       Date:  2006       Impact factor: 1.890

7.  Progress in rational methods of cryoprotection in macromolecular crystallography.

Authors:  Thomas Alcorn; Douglas H Juers
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  5 in total

1.  Crystallization and preliminary X-ray diffraction analysis of two peptides from Alzheimer PHF in complex with the MN423 antibody Fab fragment.

Authors:  Rostislav Skrabana; Ondrej Cehlar; Zuzana Flachbartova; Andrej Kovac; Jozef Sevcik; Michal Novak
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-09-25

2.  Polymeric alkylpyridinium salts permit intracellular delivery of human Tau in rat hippocampal neurons: requirement of Tau phosphorylation for functional deficits.

Authors:  Dave J Koss; Lianne Robinson; Anna Mietelska-Porowska; Anna Gasiorowska; Kristina Sepčić; Tom Turk; Marcel Jaspars; Grazyna Niewiadomska; Roderick H Scott; Bettina Platt; Gernot Riedel
Journal:  Cell Mol Life Sci       Date:  2015-06-13       Impact factor: 9.261

3.  Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer's disease.

Authors:  Eva Kontsekova; Norbert Zilka; Branislav Kovacech; Rostislav Skrabana; Michal Novak
Journal:  Alzheimers Res Ther       Date:  2014-08-01       Impact factor: 6.982

4.  Humanized tau antibodies promote tau uptake by human microglia without any increase of inflammation.

Authors:  Monika Zilkova; Anna Nolle; Branislav Kovacech; Eva Kontsekova; Petronela Weisova; Peter Filipcik; Rostislav Skrabana; Michal Prcina; Tomas Hromadka; Ondrej Cehlar; Gabriela Paulikova Rolkova; Denisa Maderova; Michal Novak; Norbert Zilka; Jeroen J M Hoozemans
Journal:  Acta Neuropathol Commun       Date:  2020-05-29       Impact factor: 7.801

5.  A New Spectral Shift-Based Method to Characterize Molecular Interactions.

Authors:  Andreas Langer; Tanja Bartoschik; Ondrej Cehlar; Stefan Duhr; Philipp Baaske; Werner Streicher
Journal:  Assay Drug Dev Technol       Date:  2022-02-15       Impact factor: 1.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.